Law360, New York (June 11, 2010, 4:44 PM ET) -- A federal judge has dismissed with prejudice two class action complaints from consumers and third-party payors accusing Schering-Plough Corp. of improperly marketing drugs for off-label use, closing the book on litigation that has plagued the former pharma giant since 2006.
The consumer class lacked standing because lead plaintiff Angela Montgomery could not prove a nexus between the defendants’ actions and her alleged injury, while third-party payors failed to sufficiently plead Racketeer Influenced and Corrupt Organizations Act claims, Judge Stanley R. Chesler of the U.S. District Court...
Schering-Plough Off-Label Marketing MDL Dunzo
To view the full article, take a free trial now.
